EUVIMEDEUVIMED entdecken
Crossref

Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth

María Fernanda García-Cedillo, Federico Ulises Villegas-García, Josealberto Sebastiano Arenas-Martinez, Victoria Jaqueline Ornelas-Arroyo, Jesús Kazuo Yamamoto-Furusho, Luis Alberto Estrella-Sato, Enrique Coss-Adame

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-024-08767-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von María Fernanda García-Cedillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Mexico City, Mexico. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Intestine, Small, Lactase, Rifamycins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeIntestine, SmallLactaseRifamycinsGastrointestinal AgentsHumansRifaximinMaleFemalePilot ProjectsAdultMiddle AgedProspective StudiesBreath TestsBlind Loop SyndromeTreatment OutcomeLactuloseXylose

Stichwörter der Autor:innen

FODMAPIBSLactase activityLactoseMaldigestionSIBO

Substanzen

RifaximinLactaseRifamycinsGastrointestinal AgentsLactuloseXylose

Autor:innen und Institutionen

  • Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Gastrointestinal Motility Laboratory, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico D.F., Mexico.
  • Department of Gastroenterology, Centro Médico Nacional la Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Gastrointestinal Motility Laboratory, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico D.F., Mexico. enrique.cossa@incmnsz.mx.

Zitieren

APA

García-Cedillo, M. F., Villegas-García, F. U., Arenas-Martinez, J. S., Ornelas-Arroyo, V. J., Yamamoto-Furusho, J. K., Estrella-Sato, L. A., & Coss-Adame, E. (2025). Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08767-1

Vancouver

García-Cedillo MF, Villegas-García FU, Arenas-Martinez JS, Ornelas-Arroyo VJ, Yamamoto-Furusho JK, Estrella-Sato LA, et al. Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-024-08767-1

BibTeX
@article{GarcaCedillo2025,
  author = {García-Cedillo, María Fernanda and Villegas-García, Federico Ulises and Arenas-Martinez, Josealberto Sebastiano and Ornelas-Arroyo, Victoria Jaqueline and Yamamoto-Furusho, Jesús Kazuo and Estrella-Sato, Luis Alberto and Coss-Adame, Enrique},
  title = {Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-024-08767-1}
}
Kostenlos starten →